• 1. An antioxidative galactomannan extracted from Chinese Sesbania cannabina enhances immune activation of macrophage cells?
  Chongyang Zhu,Xiaojia Bian,Xin Jia,Ning Tang,Yongqiang Cheng Food Funct., 2020,11, 10635-10644
• 2. An arsenic trioxide nanoparticle prodrug (ATONP) potentiates a therapeutic effect on an aggressive hepatocellular carcinoma model via enhancement of intratumoral arsenic accumulation and disturbance of the tumor microenvironment?
  Xin Fu,Qing-rong Liang,Rong-guang Luo,Yan-shu Li,Xiao-ping Xiao,Lu-lu Yu,Wen-zhe Shan,Guang-qin Fan J. Mater. Chem. B, 2019,7, 3088-3099
• 3. An ionic liquid-based synergistic extraction strategy for rare earths?
  Yingbo Li,Nada Mehio,Huizhou Liu,Sheng Dai Green Chem., 2015,17, 2981-2993
• 4. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
• 5. An aptamer-based keypad lock system?
  Yaqing Liu,Jiangtao Ren,Jing Li,Jiyang Liu,Erkang Wang Chem. Commun., 2012,48, 802-804

• Catalysts and Inorganic Chemicals Inorganic Compounds Salt

Recent Advances in the Application of Sulfuric Acid, Titanium(4+) Salt (2:1) (CAS 13693-11-3) in Chemical Biomedicine

The compound Sulfuric acid, titanium(4+) salt (2:1), with the CAS number 13693-11-3, has garnered significant attention in recent chemical biomedicine research due to its unique properties and potential applications. This inorganic compound, commonly referred to as titanium sulfate, exhibits remarkable catalytic and photocatalytic activities, making it a promising candidate for various biomedical and pharmaceutical applications. Recent studies have explored its utility in drug delivery systems, antimicrobial coatings, and as a catalyst in organic synthesis, particularly in the production of active pharmaceutical ingredients (APIs).

One of the most notable advancements in the application of titanium sulfate is its role in the development of novel drug delivery systems. Researchers have leveraged its ability to form stable complexes with organic molecules to create controlled-release formulations. A 2023 study published in the Journal of Controlled Release demonstrated that titanium sulfate-based nanoparticles could effectively encapsulate hydrophobic drugs, enhancing their solubility and bioavailability. The study highlighted the compound's biocompatibility and low toxicity, which are critical factors for in vivo applications.

In addition to drug delivery, titanium sulfate has shown promise in antimicrobial applications. A recent investigation published in ACS Applied Materials & Interfaces revealed that coatings incorporating titanium sulfate exhibited potent antibacterial activity against multidrug-resistant strains such as MRSA. The mechanism of action was attributed to the generation of reactive oxygen species (ROS) under light irradiation, which disrupt bacterial cell membranes. This finding opens new avenues for developing self-disinfecting surfaces in healthcare settings, potentially reducing the incidence of hospital-acquired infections.

Another area of interest is the catalytic properties of titanium sulfate in organic synthesis. A 2024 study in Organic Letters reported its efficacy as a Lewis acid catalyst in the synthesis of heterocyclic compounds, which are prevalent in many pharmaceuticals. The researchers noted that titanium sulfate offered several advantages over traditional catalysts, including higher yields, milder reaction conditions, and easier recyclability. These attributes make it an attractive option for green chemistry initiatives in the pharmaceutical industry.

Despite these promising developments, challenges remain in the widespread adoption of titanium sulfate in biomedicine. Issues such as long-term stability, scalability of synthesis, and comprehensive toxicity profiling need to be addressed. Ongoing research is focused on optimizing the compound's properties and exploring its potential in other areas, such as cancer therapy and diagnostic imaging. For instance, preliminary studies suggest that titanium sulfate-based contrast agents could enhance the resolution of magnetic resonance imaging (MRI).

In conclusion, Sulfuric acid, titanium(4+) salt (2:1) (CAS 13693-11-3) represents a versatile and promising material in the field of chemical biomedicine. Its applications in drug delivery, antimicrobial coatings, and organic synthesis underscore its potential to address some of the most pressing challenges in healthcare and pharmaceuticals. As research continues to uncover new uses and refine existing ones, this compound is poised to play an increasingly important role in advancing biomedical technologies.

• 27960-69-6(Sulfuric acid,titanium(4+) salt (1:?))
• 19414-43-8(Sulfuric acid,titanium(3+) salt (2:1), hydrate (2:5) (8CI))
• 590401-67-5(Sulfate, hexahydrate)
• 590401-70-0(Sulfate, dodecahydrate)
• 590401-65-3(Sulfate, pentahydrate)
• 10343-61-0(dititanium tris(sulphate))
• 19495-80-8(Sulfuric acid,titanium(3+) salt (2:1), tetrahydrate (8CI,9CI))
• 13825-74-6(titanium(iv) oxysulfate)
• 18130-44-4(Sulfuric acid, titaniumsalt (8CI,9CI))
• 590401-64-2(Sulfate, trihydrate)